Using pomegranate seed powder to improve metabolic syndrome markers
Therapeutic Effects of Pomegranate Seed Powder on Metabolic Syndrome Markers
This study is testing if taking pomegranate seed powder can help people with metabolic syndrome improve their health markers like blood sugar, cholesterol, and weight.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 30 Years to 60 Years |
| Sex | All |
| Sponsor | University of Veterinary and Animal Sciences, Lahore - Pakistan Academic / other |
| Locations | 1 site (Lahore, Punjab) |
| Trial ID | NCT05944029 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effects of pomegranate seed powder on individuals with metabolic syndrome, a condition characterized by obesity, high blood sugar, high triglycerides, hypertension, and low HDL cholesterol. Over 8 weeks, 50 participants will receive a dose of pomegranate seed powder twice daily, with their biochemical markers such as blood pressure, fasting blood glucose, cholesterol, and weight measured before and after the intervention. The study aims to determine the therapeutic efficiency of pomegranate seed powder in managing metabolic syndrome-related indicators.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 30-55 with a BMI over 25 and indicators of dyslipidemia or altered blood glucose levels.
Not a fit: Patients with thyroid disorders, liver disease, kidney disorders, or cancer may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a natural dietary intervention for managing metabolic syndrome and its associated health risks.
How similar studies have performed: Previous studies have shown promising results regarding the health benefits of pomegranate in managing metabolic conditions, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * BMI \> 25kg/m2 * Dyslipidemia * Altered blood glucose level * Age 30-55 ( male and female) Exclusion Criteria: * Thyroid disorder * Liver disease * Kidney disorder * Cancer etc
Where this trial is running
Lahore, Punjab
- University of Veterinary and Animal sciences Lahore — Lahore, Punjab, Pakistan (Recruiting)
Study contacts
- Study coordinator: Shahbano Zahid, Mphil
- Email: shahbanozahid265@gmail.com
- Phone: +923095563643
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.